CCL2 and nonpapillary renal cell carcinoma: In order to further strengthen the prognostic value of CCL2/CCR2 signature for clinical outcome, we developed a postoperative nomogram to predict long-term overall survival and recurrence-free survival of non-metastatic ccRCC patients based on 10-year follow-up.